Oxidative stress biomarkers in sporadic ALS

References

• Rowland LP. The cause of sporadic ALS. Amyotrophic Lateral Sclerosis, H PS Mitsumoto, PH Gordon. Taylor and Francis, New York 2006; 81–98
   Google Scholar
• Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723–49
   PubMed Web of Science ®Google Scholar
• Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neuron disease. J Neurol Neurosurg Psychiatry. 2005; 76: 1046–57
   PubMed Web of Science ®Google Scholar
• Andersen JK. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004; 10((Suppl))S18–25
   PubMed Web of Science ®Google Scholar
• Beckman JS EA., Esteves AG. Superoxide dismutase, oxidative stress, and ALS. Amyotrophic Lateral Sclerosis, H Mitsumoto, S Perzedborski, PH Gordon. Taylor and Francis, New York 2005; 339–54
   Google Scholar
• Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O'Donnell H, et al. Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med. 2000; 29: 652–8
   PubMed Web of Science ®Google Scholar
• Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 2004; 62: 1758–65
   PubMed Web of Science ®Google Scholar
• Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (phase II study). Amyotroph Lateral Scler. 2006; 7: 241–5
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot D, Lacomblez L, Jaudon M, Lepage S, Salachas F, Bensimon G, et al. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci. 2000; 178: 57–62
   PubMed Web of Science ®Google Scholar
• Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, et al. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol. 2000; 47: 524–7
   PubMed Web of Science ®Google Scholar
• Kaufmann E, Boehm BO, Sussmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, et al. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2004; 371: 226–9
   PubMed Web of Science ®Google Scholar
• Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 827: 65–75
   PubMed Web of Science ®Google Scholar
• Beckman KB, Ames BN. Endogenous oxidative damage of mtDNA. Mutation Research. 1999; 424: 51–8
   PubMed Web of Science ®Google Scholar
• de Souza-Pinto NC, Eide L, Hogue BA, Thybo T, Stevnsner T, Seeberg E, et al. Repair of 8-oxodeoxyguanosine lesions in mitochondrial DNA depends on the oxoguanine DNA glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial DNA of OGG1-defective mice. Cancer Research. 2001; 61: 5378–81
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes PJ, Roberts LJ 2nd. Isoprostanes: markers and mediators of oxidative stress. Faseb J. 2004; 18: 1791–800
   PubMed Web of Science ®Google Scholar
• Rossner P, Jr, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, et al. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006; 15: 639–44
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006; 10: 389–406
   PubMed Web of Science ®Google Scholar
• World Federation NRGoAS. Revised El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. 2000 ( cited; Available from: www.wfnals.org)
   Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13–21
   PubMed Web of Science ®Google Scholar
• Yin B, Whyatt RM, Perera FP, Randall MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med. 1995; 18: 1023–32
   PubMed Web of Science ®Google Scholar
• Bogdanov MB, Beal MF, McCabe DR, Griffin RM, Matson WR. A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2′-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radic Biol Med. 1999; 27: 647–66
   PubMed Web of Science ®Google Scholar
• Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev. 2000; 32: 377–85
   PubMed Web of Science ®Google Scholar
• Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med. 1997; 23: 361–6
   PubMed Web of Science ®Google Scholar
• Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A. 2005; 102: 5618–23
   PubMed Web of Science ®Google Scholar
• Ward WF, Qi W, van Remmen H, Zackert WE, Roberts LJ 2nd, Richardson A. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J Gerontol A Biol Sci Med Sci. 2005; 60: 847–51
   PubMed Web of Science ®Google Scholar
• Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol Biomarkers Prev. 2002; 11: 767–70
   PubMed Web of Science ®Google Scholar
• Appel SH. Is ALS a systemic disorder? Evidence from muscle mitochondria. Exp Neurol. 2006; 198: 1–3
   PubMed Web of Science ®Google Scholar
• Lancero HL, Do H, Gascon R, Lancero MG, Narvaez A, Miller RG, et al. Observed elevated cytokines and myeloid/interferon-induced (MIFN) signature protein levels in ALS: a possible ALS early detection method. Amyotroph Lateral Scler. 2006; 7(Suppl 1)63
   Google Scholar
• Ono S. The skin in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 191–9
   PubMed Web of Science ®Google Scholar
• Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987; 22: 575–9
   PubMed Web of Science ®Google Scholar
• Nikolic-Kokic A, Stevic Z, Blagojevic D, Davidovic B, Jones DR, Spasic MB. Alterations in antioxidative defense enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med. 2006; 44: 589–93
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005; 2: 202–7
   PubMed Web of Science ®Google Scholar
• Dupuis L, Gonzalez de Aguilar JL, Oudart H, de Tapia M, Barbeito L, Loeffler JP. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis. 2004; 1: 245–54
   PubMed Web of Science ®Google Scholar
• Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007; 66: 10–6
   PubMed Web of Science ®Google Scholar
• Finsterer J. Mitochondriopathy mimicking amyotrophic lateral sclerosis. Neurologist. 2003; 9: 45–8
   PubMed Web of Science ®Google Scholar
• Moylan JS, Reid MB. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve. 2007; 35: 411–29
   PubMed Web of Science ®Google Scholar
• Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, Siedlak SL, et al. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer's disease. Molecular Neurodegeneration. 2007; 2: 2
   PubMed Web of Science ®Google Scholar
• Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, et al. Creatine in Huntington's disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology. 2006; 66: 250–2
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Takeda A, Onodera H, Kimpara T, Hisanaga K, Sato N, et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis. 2002; 9: 244–8
   PubMed Web of Science ®Google Scholar
• Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, et al. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 1999; 52: 562–5
   PubMed Web of Science ®Google Scholar
• Sato S, Mizuno Y, Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson's disease. Neurology. 2005; 64: 1081–3
   PubMed Web of Science ®Google Scholar
• Mantovani G, Maccio A, Madeddu C, Massa E. Cancer-related cachexia and oxidative stress: beyond current therapeutic options. Expert review of anticancer therapy. 2003; 3: 381–92
   PubMedGoogle Scholar
• Balasubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Current opinion in pulmonary medicine. 2006; 12: 106–12
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Brennan ML, Hazen SL. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2006; 48: 59–68
   PubMed Web of Science ®Google Scholar
• Norris FH, Denys EH, Uxxx KS. Old and new clinical problems in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis, T Tsubaki, Y Toyokura. University Park Press, Baltimore 1978; 3–26
   Google Scholar
• Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53: 1059–63
   PubMed Web of Science ®Google Scholar
• McGuire V, Nelson LM. Epidemiology of ALS. Amyotrophic Lateral Sclerosis, H PS Mitsumoto, PH Gordon. Taylor and Francis, New York 2006; 17–42
   Google Scholar
• Abou-Donia MB. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health. 2003; 58: 484–97
   PubMed Web of Science ®Google Scholar
• Kovacic P. Mechanism of organophosphates (nerve gases and pesticides) and antidotes: electron transfer and oxidative stress. Curr Med Chem. 2003; 10: 2705–9
   PubMed Web of Science ®Google Scholar
• Luo J, Shi R. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem Int. 2004; 44: 475–86
   PubMed Web of Science ®Google Scholar
• Schmuck G, Rohrdanz E, Tran-Thi QH, Kahl R, Schluter G. Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro. Neurotox Res. 2002; 4: 1–13
   PubMed Web of Science ®Google Scholar
• Chetty CS, Vemuri MC, Campbell K, Suresh C. Lead-induced cell death of human neuroblastoma cells involves GSH deprivation. Cell Mol Biol Lett. 2005; 10: 413–23
   PubMed Web of Science ®Google Scholar
• Fowler BA, Whittaker MH, Lipsky M, Wang G, Chen XQ. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats – an overview. Biometals. 2004; 17: 567–8
   PubMed Web of Science ®Google Scholar
• Qian Y, Zheng Y, Ramos KS, Tiffany-Castiglioni E. The involvement of copper transporter in lead-induced oxidative stress in astroglia. Neurochem Res. 2005; 30: 429–38
   PubMed Web of Science ®Google Scholar
• Lai H, Singh NP. Magnetic-field-induced DNA strand breaks in brain cells of the rat. Environ Health Perspect. 2004; 112: 687–94
   PubMed Web of Science ®Google Scholar
• Nelson LM, McGuire V, Longstreth WT, Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000; 151: 156–63
   PubMed Web of Science ®Google Scholar
• Vayssier M, Banzet N, Francois D, Bellmann K, Polla BS. Tobacco smoke induces both apoptosis and necrosis in mammalian cells: differential effects of HSP70. Am J Physiol. 1998; 275: L771–9
   PubMed Web of Science ®Google Scholar
• Vollaard NB, Shearman JP, Cooper CE. Exercise-induced oxidative stress: myths, realities and physiological relevance. Sports Med. 2005; 35: 1045–62
   PubMed Web of Science ®Google Scholar
• Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005; 135: 659–78
   PubMed Web of Science ®Google Scholar
• Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61: 742–9
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology. 2005; 64: 32–7
   PubMed Web of Science ®Google Scholar